Medications for Biliary Tract Cancer

2 results

  • imfinzi - durvalumab injection, solution

    (Durvalumab)
    Astrazeneca Pharmaceuticals Lp
    Imfinzi is a PD-L1 antibody indicated for adults with NSCLC (resectable, unresectable Stage III, or metastatic), limited- and extensive-stage SCLC, biliary tract cancer, unresectable hepatocellular carcinoma, dMMR endometrial cancer, muscle-invasive bladder cancer, and resectable gastric/GEJ adenocarcinoma. Administered as monotherapy or with chemotherapy.
    Medication Details
    Drug Interactions

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions